TY  - CHAP
M1  - Book, Section
TI  - Exercise and Pharmacologic Stress Testing
A1  - Hendel, Robert C.
A1  - Ramireddy, Archana
A2  - Heller, Gary V.
A2  - Hendel, Robert C.
Y1  - 2017
N1  - 
T2  - Nuclear Cardiology: Practical Applications, 3e
AB  - Using  radiopharmaceuticals  to  visualize  the  regional  distribution  of  myocardial  perfusion  during  rest  and  stress  is  a  well-established  modality  for  the  evaluation  of  known  or  suspected  coronary  artery  disease  (CAD).  In  1964,  the  first  scintigraphic  images  of  myocardial  perfusion  were  acquired  by  Carrea  et  al.,1  while  Zaret  et  al.  were  the  first  to  demonstrate  exercise-induced  myocardial  ischemia  using  radioactive  potassium  in  1973.2  Since  then,  the  field  of  nuclear  cardiology  has  grown  dramatically,  and  numerous  studies  have  validated  the  utility  of  both  exercise  and  pharmacologic  stress  myocardial  perfusion  imaging  (MPI)  for  risk  assessment  and  the  prediction  of  future  cardiac  events.  With  >8  million  such  studies  being  performed  yearly  in  the  United  States  alone,  understanding  the  logistics  of  and  options  available  for  radionuclide  stress  testing  is  critical.3  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesscardiology.mhmedical.com/content.aspx?aid=1145443589
ER  -